Burden of Diabetes Mellitus in a Community Resident in an Area Designated as “High Risk” for Chronic Kidney Disease of Unknown Origin in Sri Lanka

Authors

  • Pubudu Chulasiri Consultant Community Physician, Anti-malaria Campaign, Ministry of Health, Colombo, Sri Lanka
  • Nimali Widanapathirana SeniorRegistrar, Ministry of Health, Sri Lanka
  • Sameera Senanayake PhD Candidate, Queensland University of Technology, Australia
  • Thilanga Ruwanpathirana Consultant Community Physician, Epidemiology Unit, Ministry of Health, Sri Lanka
  • Nalika Gunawardana National Program Officer, World Health Organization, Country Office, Sri Lanka

DOI:

https://doi.org/10.21276/apjhs.2021.8.1.7

Keywords:

Burden, Chronic kidney disease, Community, Diabetes mellitus, High risk

Abstract

Chronic kidney disease (CKD) where etiology cannot be attributed to any known etiology is named CKD of uncertain etiology (CKDu). The main aims of this study were to assess the prevalence of diabetes mellitus (DM), treatment coverage, and glycemic control and its effect on renal function of patients with DM in a rural community affected by CKDu in Sri Lanka. A cross-sectional representative household survey (n = 4803) was conducted in Anuradhapura district. A random blood sugar (RBS), blood pressure, bio-impedance measurements, and renal profile were measured using standard instruments and protocols. Prevalence of DM based on self-reports verified by records was 7.9% (95% confidence interval [CI]: 7.1–8.7). Among the 4425 who did not give a history of being diagnosed ever as having DM, 2.1% (95% CI: 1.7–2.5) were classified as “possible diabetes” (RBS of more than 200 mg/dl with no history of DM). Although 76.2% were on treatment, glycemic control was poor in 40.2% (95% CI: 34.9–45.0). The presence of DM was associated with poor renal function. One in ten individuals in the rural district of Anuradhapura has possible DM. DM poses a significant burden to CKD even in populations affected by CKDu. Hence, public health initiatives should be implemented to control both CKDu and DM in these rural communities.

Downloads

Download data is not yet available.

References

International Diabetes Federation. International Diabetes Federation. IDF Diabetes Atlas 9th ed. Brussels, Belgium: International Diabetes Federation; 2019, Available from: https://www.diabetesatlas.org/en. [Last accessed on 2020 Aug 12].

Ranasinghe P, Jayawardena R, Katulanda P. The facts, figures, and reality of the diabetes epidemic in Sri Lanka: A systematic review. Int J Diabetes Dev Ctries 2015;35:501-13.

World Health Organization. Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycaemia: Report of a WHO/IDF Consultation. Geneva: World Health Organization; 2006. Available from: https://www.who.int/diabetes/publications/Definition%20and%20diagnosis%20of%20diabetes_new.pdf.[Last accessed on 2020 Sep 08].

González BS, Pascual MR, Guijarro LR, González AF, Puertolas OC, Latre LM. Chronic kidney disease in primary health care: Prevalence and associated risk factors. Aten Primaria 2015;47:236-45.

The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.

UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with Type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.

Senanayake SJ. Chronic kidney disease in Sri Lanka: A glimpse into lives of the affected. J Coll Community Physicians Sri Lanka 2018;24:56-65.

Ruwanpathirana T, Senanayake S, Gunawardana N, Munasinghe A, Ginige S, Gamage D, et al. Prevalence and risk factors for impaired kidney function in the district of Anuradhapura, Sri Lanka: A cross-sectional population-representative survey in those at risk of chronic kidney disease of unknown aetiology. BMC Public Health 2019;19:763.

Epidemiology Unit. Prevalence and Risk Factors for CKDu in the District of Anuradhapura. Colombo. Sri Lanka: Epidemiology Unit, Ministry of Health. Epidemiology Unit; 2018.

Abramson J, Abramson ZH. Research Methods in Community Medicine: Surveys, Epidemiological Research, Programme Evaluation, Clinical Trials. Hoboken, New Jersey: Wiley; 2011.

Katulanda P, Rathnapala D, Sheriff MH, Matthews D. Province and ethnic specific prevalence of diabetes among Sri Lankan adults. Sri Lanka J Diabetes Endocrinol Metab 2012;1:2-7.

Katulanda P, Constantine GR, Mahesh JG, Sheriff R, Seneviratne RD, Wijeratne S, et al. Prevalence and projections of diabetes and pre-diabetes in adults in Sri Lanka--Sri Lanka diabetes, cardiovascular study (SLDCS). Diabet Med 2008;25:1062-9.

Mallawaarachchi DS, Wickremasinghe SC, Somatunga LC, Siriwardena VT, Gunawardena NS. Healthy lifestyle centres: A service for screening noncommunicable diseases through primary health-care institutions in Sri Lanka. WHO South East Asia J Public Health 2016;5:89-95.

Pinidiyapathirage MJ, Kasturiratne A, Ranawaka UK, Gunasekara D, Wijekoon N, Medagoda K, et al. The burden of diabetes mellitus and impaired fasting glucose in an urban population of Sri Lanka. Diabet Med 2013;30:326-32.

De Silva AP, De Silva SH, Liyanage IK, Rajapakse LC, Jayasinghe KS, Katulanda P, et al. Social, cultural and economical determinants of diabetes mellitus in Kalutara district, Sri Lanka: A cross sectional descriptive study. Int J Equity Health 2012;11:76.

Govindaraj R, Navaratne K, Cavagnero E, Seshadri SR. Health Care in Sri Lanka: What Can the Private Health Sector Offer? Health, Nutrition and Population (HNP) Discussion Paper Series 89554. Washington, DC: The World Bank; 2014.

Downloads

Published

2021-01-26

How to Cite

Pubudu Chulasiri, Nimali Widanapathirana, Sameera Senanayake, Thilanga Ruwanpathirana, & Nalika Gunawardana. (2021). Burden of Diabetes Mellitus in a Community Resident in an Area Designated as “High Risk” for Chronic Kidney Disease of Unknown Origin in Sri Lanka. Asian Pacific Journal of Health Sciences, 8(1), 32–37. https://doi.org/10.21276/apjhs.2021.8.1.7